Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

1.720 -0.080 (-4.44%)
Streaming Delayed Price Updated: 12:10 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immuron Limited - American Depositary Shares

< Previous 1 2 3 Next >
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
From Immuron Limited
Via GlobeNewswire
Immuron Announces Travelan® Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Via ACCESSWIRE
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
From Immuron Limited
Via GlobeNewswire
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
From Immuron Limited
Via GlobeNewswire
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
From Immuron Limited
Via GlobeNewswire
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
From Immuron Limited
Via GlobeNewswire
Immuron announces record Travelan® sales globally, Australia and USA
From Immuron Limited
Via GlobeNewswire
Immuron requests pre-IND meeting for IMM-529 with FDA filing
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron Board Changes
From Immuron Limited
Via GlobeNewswire
Immuron CEO Steven Lydeamore to present at Peak Sky High
From Immuron Limited
Via GlobeNewswire
Immuron Limited to Present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Immuron Director Resignation
From Immuron Limited
Via GlobeNewswire
Immuron to host Live Virtual Event
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® sales continued strong growth
From Immuron Limited
Via GlobeNewswire
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
From Immuron Limited
Via GlobeNewswire
Immuron Presentation Australian Biologics Festival 2024
From Immuron Limited
Via GlobeNewswire
Immuron achieves record Travelan® sales
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.